RESILIA PHARMACEUTICALS, INC.
Live / Registered — Registered (as of 25 Jul 2023)
What this means for you
Registered since 25 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90448108
- Registration number
- 7122330
- Mark type
- Design + words
- Filed
- 05 Jan 2021
- Published for opposition
- 07 Dec 2021
- Registered
- 25 Jul 2023
- Attorney of record
- Julie Beth Albert
Goods and services
- Class 005 — Pharmaceuticals: Dermatological pharmaceutical products; Pharmaceutical skin lotions; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating skin disorders
Owner
- Peak Pharma Commercial Partners, LLC, New York, NY, US
- Peak Pharma Commercial Partners, LLC, New York, NY, US
- Peak Pharma Commercial Partners, LLC, New York, NY, US
Prosecution history
- 25 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 08 May 2023 — USE AMENDMENT FILED
- 30 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 31 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2023 — SOU EXTENSION 2 GRANTED
- 27 Jan 2023 — SOU EXTENSION 2 FILED
- 27 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2022 — SOU EXTENSION 1 GRANTED